Understanding the beneficial role of glucagon-like peptide-1 (GLP-1) for normalizing intestinal lipoprotein metabolism during insulin resistance
Understanding the beneficial role of glucagon-like peptide-1 (GLP-1) for normalizing intestinal lipoprotein metabolism during insulin resistance
了解胰高血糖素样肽 1 (GLP-1) 在胰岛素抵抗期间使肠道脂蛋白代谢正常化的有益作用
批准号：
283892
负责人：
Farr Sarah L
金额：
$7.65万
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-10-01 至 2015-10-01
中文摘要
翻译
2型糖尿病已被列为全球流行病，目前有2.85亿人受到影响；到2030年，这一数字预计将达到4.39亿。虽然这种情况会导致高血糖，但异常
英文摘要
Type 2 diabetes has been labelled a world-wide epidemic, with 285 million individuals currently affected; a number that is expected to reach 439 million by the year 2030. Though this condition is known for causing high blood sugar levels, abnormalities in
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bile acid signaling as a novel regulator of postprandial lipemia and intestinal lipoprotein production
-
批准号：352433
-
项目类别：
-
资助金额：$0.07万
-
财政年份：2016
-
负责人：Farr Sarah L
-
依托单位：
Understanding the beneficial role of glucagon-like peptide-1 (GLP-1) for normalizing intestinal lipoprotein metabolism during insulin resistance
-
批准号：255025
-
项目类别：Studentship Programs
-
资助金额：$1.27万
-
财政年份：2012
-
负责人：Farr Sarah L
-
依托单位：
海外基金
